With the completion of this second phase, the Metro-3 will officially enter the island city, making travel more convenient for Mumbaikars. This phase will connect key locations such as Dharavi and ...

This underground corridor will provide access to key locations ... Phase-5, four will be entirely new. These include the Mayapuri to Kashmiri Gate, CGO Complex to Surya Vihar (Faridabad), Mayur Vihar ...

The recognition has been granted to Konanakunte Cross, Doddakallasandra, Vajarahalli, Talaghattapura, and Silk Institute stations on Reach-4B of Namma Metro. The Bangalore Metro Rail Corporation ...

From entrance and exit signs to platform directional signs and Metro Station names updated Dubai: When residents were asleep after the Eid Al Fitr celebrations over the past few days, the workers ...

INDIA: Bengaluru operator Bangalore Metro Rail Corp has ordered a further seven six-car metro trainsets from BEML as part of ...

The Indian Premier League (IPL) 2025 season is underway, and Bangalore's cricket fever has kicked in, so the Bangalore Metro ...

The Delhi Metro Rail Corporation ... for the 118.9 km phase II network with 128 stations. The phase II network comprises three corridors — Madhavaram to SIPCOT (corridor 3), Light House to ...

the Bangalore Metro Rail Corporation Limited (BMRCL) has announced an extension of its metro services on match days. The last train from all four terminal stations will now depart at 12:30 am ...

Check new timings (Photo Source: X(Twitter) The Indian Premier League 2025 (IPL) season is underway, and the excitement is ...

Bengaluru Metro will extend its last train departures to 12:30 am from all four terminal stations on IPL match days. Matches are scheduled for April 2, 10, 18, 24, and May 3, 13, 17 ... 13th and 17th ...

Its rival Moderna said earlier this month, however, that it has already fully enrolled a 6,000-subject phase 3 study of its quadrivalent vaccine candidate mRNA-1010 in the southern hemisphere ...

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...